NasdaqCM - Nasdaq Real Time Price USD
Moleculin Biotech, Inc. (MBRX)
1.0648
+0.0348
+(3.37%)
As of 9:37:34 AM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
16,925
38,217
57,422
84,090
Total Liabilities Net Minority Interest
10,946
12,144
5,231
5,097
Total Equity Gross Minority Interest
5,979
26,073
52,191
78,993
Total Capitalization
5,979
26,073
52,191
78,993
Common Stock Equity
5,979
26,073
52,191
78,993
Capital Lease Obligations
478
574
451
159
Net Tangible Assets
-5,169
14,925
41,043
67,845
Working Capital
-165
19,458
40,777
68,875
Invested Capital
5,979
26,073
52,191
78,993
Tangible Book Value
-5,169
14,925
41,043
67,845
Total Debt
478
574
451
159
Share Issued
3,378.8950
2,227.5160
1,908.5210
1,905.2220
Ordinary Shares Number
3,378.8950
2,227.5160
1,908.5210
1,905.2220
12/31/2021 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNSP CNS Pharmaceuticals, Inc.
0.9691
+1.50%
PHIO Phio Pharmaceuticals Corp.
2.3600
+15.69%
IVVD Invivyd, Inc.
0.6177
-4.13%
PSTV Plus Therapeutics, Inc.
0.9450
-3.91%
XLO Xilio Therapeutics, Inc.
0.8000
+0.77%
KTTA Pasithea Therapeutics Corp.
1.6600
+1.84%
RNAZ TransCode Therapeutics, Inc.
0.3220
+2.55%
EDSA Edesa Biotech, Inc.
2.3700
+0.42%
MIST Milestone Pharmaceuticals Inc.
1.1300
-2.61%
CAPR Capricor Therapeutics, Inc.
13.27
+0.91%